Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.45% |
| 2 | Technology | 8.65% |
| 3 | Financials | 8.6% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Truist Financial
TFC
$62.1B
| $34.9M | 0.04% |
620,506
+43,775
| +8% | +$2.37M |
|
|
INXN
527
DELISTED
Interxion Holding N.V.
INXN
| $34.9M | 0.04% |
416,299
+269,715
| +184% | +$22.5M |
|
528
Herbalife
HLF
$1.32B
| $34.8M | 0.04% |
730,165
+587,087
| +410% | +$25.4M |
|
529
CALL
Cisco
CSCO
$434B
| $34.8M | 0.04% |
724,800
+594,000
| +454% | +$27.6M |
|
|
530
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$819B
| $34.8M | 0.04% |
108,000
-491,900
| -82% | -$151M |
|
531
Eversource Energy
ES
$26.8B
| $34.7M | 0.04% |
408,473
+394,802
| +2,888% | +$32.8M |
|
532
PUT
iShares MSCI EAFE ETF
EFA
$79.9B
| $34.7M | 0.04% |
+500,000
| New | +$33.8M |
|
533
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.06B
| $34.6M | 0.04% |
594,800
+555,700
| +1,421% | +$30.8M |
|
534
Aecom
ACM
$8.36B
| $34.5M | 0.04% |
799,132
-746,758
| -48% | -$30.9M |
|
535
Vale
VALE
$64B
| $34.4M | 0.04% |
2,606,977
+1,894,740
| +266% | +$22.8M |
|
536
TG Therapeutics
TGTX
$8.57B
| $34.4M | 0.04% |
3,097,043
-4,424,867
| -59% | -$33.6M |
|
537
Simply Good Foods
SMPL
$970M
| $34.3M | 0.04% |
1,202,830
+738,082
| +159% | +$19.5M |
|
538
BioCryst Pharmaceuticals
BCRX
$2.47B
| $34.3M | 0.04% |
9,940,677
+2,177,342
| +28% | +$5.48M |
|
539
iShares Biotechnology ETF
IBB
$10.7B
| $34.2M | 0.04% |
284,103
-106,963
| -27% | -$11.9M |
|
540
PepsiCo
PEP
$197B
| $34.2M | 0.04% |
250,106
-660,765
| -73% | -$89.9M |
|
541
Hasbro
HAS
$13.5B
| $34.1M | 0.04% |
322,580
+295,848
| +1,107% | +$30.8M |
|
542
Cannae Holdings
CNNE
$668M
| $33.9M | 0.04% |
912,492
-420,915
| -32% | -$13.8M |
|
543
Fortinet
FTNT
$112B
| $33.7M | 0.04% |
1,580,255
-1,134,230
| -42% | -$21.3M |
|
544
PUT
Royal Caribbean
RCL
$78.4B
| $33.7M | 0.04% |
252,200
+218,400
| +646% | +$25.5M |
|
545
Saic
SAIC
$5.36B
| $33.5M | 0.04% |
385,178
-459,411
| -54% | -$38.4M |
|
546
Ulta Beauty
ULTA
$23.2B
| $33.5M | 0.04% |
132,231
+64,542
| +95% | +$15.8M |
|
547
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.79B
| $33.4M | 0.04% |
352,225
+23,725
| +7% | +$2.06M |
|
|
CERN
548
DELISTED
Cerner Corp
CERN
| $33.4M | 0.04% |
454,938
+315,818
| +227% | +$21.8M |
|
549
Verizon
VZ
$208B
| $33.4M | 0.04% |
543,459
-204,855
| -27% | -$12.4M |
|
550
DXC Technology
DXC
$1.7B
| $33.1M | 0.04% |
881,836
+415,393
| +89% | +$13.5M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.